← Back to Analyst Consensus 
PROF Buy
Profound Medical Corp.
Current Price —
Implied Upside —
Analysts 5
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Jan 7, 2026 | Lake Street | maintain | Buy → Buy | $12 | 47% |
| Apr 23, 2025 | Lake Street | maintain | Buy → Buy | $11 | 47% |
| Jul 16, 2024 | Stifel | upgrade | Hold → Buy | $12 | 53% |
| Mar 11, 2024 | Alliance Global Partners | maintain | Buy → Buy | $10.8 | 41% |
| Mar 8, 2024 | Stifel | maintain | Hold → Hold | $9 | 53% |
| Jan 4, 2024 | Alliance Global Partners | maintain | Buy → Buy | $12.75 | 41% |
| Nov 28, 2023 | Stifel | initiate | — → Hold | $11 | 53% |
| Aug 4, 2023 | Raymond James | downgrade | Strong Buy → Outperform | $0 | 54% |
| May 11, 2023 | TD Cowen | maintain | — → Outperform | $18 | 54% |
| May 11, 2023 | Alliance Global Partners | maintain | — → Buy | $15.75 | 41% |
| Mar 21, 2023 | Jefferies | downgrade | Buy → Equal-Weight | $10 | 52% |
| Nov 4, 2022 | Raymond James | upgrade | Outperform → Strong Buy | $0 | 54% |
| Mar 7, 2022 | Cowen & Co. | maintain | — → Outperform | $14 | — |
| Feb 22, 2022 | Raymond James | downgrade | Strong Buy → Outperform | $23 | 54% |
| Sep 15, 2020 | Jefferies | initiate | — → Buy | $0 | 52% |
| Sep 10, 2020 | Lake Street | initiate | — → Buy | $22 | 47% |
| Apr 1, 2020 | Cowen & Co. | initiate | — → Outperform | $15 | — |
Price Target Trend
Apr 26, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days